Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7888301rdf:typepubmed:Citationlld:pubmed
pubmed-article:7888301lifeskim:mentionsumls-concept:C0227651lld:lifeskim
pubmed-article:7888301lifeskim:mentionsumls-concept:C0596290lld:lifeskim
pubmed-article:7888301lifeskim:mentionsumls-concept:C0076552lld:lifeskim
pubmed-article:7888301lifeskim:mentionsumls-concept:C0243071lld:lifeskim
pubmed-article:7888301lifeskim:mentionsumls-concept:C2349975lld:lifeskim
pubmed-article:7888301pubmed:issue7lld:pubmed
pubmed-article:7888301pubmed:dateCreated1995-4-20lld:pubmed
pubmed-article:7888301pubmed:abstractTextThrombin stimulates cytosolic calcium mobilization and tritiated thymidine incorporation in rat glomerular mesangial cells. This effect may be mediated by a thrombin receptor similar to the receptor found in human platelets. In order to test this possibility, a series of analogues of the thrombin receptor peptide, SFLL-RNPNDKYEPF, was evaluated for their effects on mesangial cells. Analogues of the thrombin receptor peptide containing five, six, seven and 14 amino acids were as efficacious as thrombin with respect to calcium mobilization and thymidine incorporation, although they were significantly less potent. The dissimilarity in potency between thrombin and the thrombin receptor peptides is consistent with the kinetics of the proposed mechanism of action of the enzyme, since the cleavage by thrombin of its receptor results in a tethered ligand which is at a relatively high concentration compared to the free peptides in solution. Those thrombin receptor peptide analogues which showed decreased activity in platelets were tested in mesangial cells. Removal of serine at position one, N-acetylation, or replacement of the phenylalanine at position two with alanine resulted in analogues which were inactive in stimulating mesangial cell proliferation or calcium mobilization. In addition, those analogues which had no stimulatory effects in mesangial cells were not antagonists of SFLLRN-mediated calcium mobilization and thymidine incorporation in mesangial cells.lld:pubmed
pubmed-article:7888301pubmed:languageenglld:pubmed
pubmed-article:7888301pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7888301pubmed:citationSubsetIMlld:pubmed
pubmed-article:7888301pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7888301pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7888301pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7888301pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7888301pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7888301pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7888301pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7888301pubmed:statusMEDLINElld:pubmed
pubmed-article:7888301pubmed:monthSeplld:pubmed
pubmed-article:7888301pubmed:issn0898-6568lld:pubmed
pubmed-article:7888301pubmed:authorpubmed-author:MooreM LMLlld:pubmed
pubmed-article:7888301pubmed:authorpubmed-author:StadelJ MJMlld:pubmed
pubmed-article:7888301pubmed:authorpubmed-author:Zabko-Potapov...lld:pubmed
pubmed-article:7888301pubmed:authorpubmed-author:DytkoGGlld:pubmed
pubmed-article:7888301pubmed:authorpubmed-author:BryanW MWMlld:pubmed
pubmed-article:7888301pubmed:authorpubmed-author:HoyleKKlld:pubmed
pubmed-article:7888301pubmed:authorpubmed-author:AlbrightsonC...lld:pubmed
pubmed-article:7888301pubmed:issnTypePrintlld:pubmed
pubmed-article:7888301pubmed:volume6lld:pubmed
pubmed-article:7888301pubmed:ownerNLMlld:pubmed
pubmed-article:7888301pubmed:authorsCompleteYlld:pubmed
pubmed-article:7888301pubmed:pagination743-50lld:pubmed
pubmed-article:7888301pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:7888301pubmed:meshHeadingpubmed-meshheading:7888301-...lld:pubmed
pubmed-article:7888301pubmed:meshHeadingpubmed-meshheading:7888301-...lld:pubmed
pubmed-article:7888301pubmed:meshHeadingpubmed-meshheading:7888301-...lld:pubmed
pubmed-article:7888301pubmed:meshHeadingpubmed-meshheading:7888301-...lld:pubmed
pubmed-article:7888301pubmed:meshHeadingpubmed-meshheading:7888301-...lld:pubmed
pubmed-article:7888301pubmed:meshHeadingpubmed-meshheading:7888301-...lld:pubmed
pubmed-article:7888301pubmed:meshHeadingpubmed-meshheading:7888301-...lld:pubmed
pubmed-article:7888301pubmed:meshHeadingpubmed-meshheading:7888301-...lld:pubmed
pubmed-article:7888301pubmed:meshHeadingpubmed-meshheading:7888301-...lld:pubmed
pubmed-article:7888301pubmed:meshHeadingpubmed-meshheading:7888301-...lld:pubmed
pubmed-article:7888301pubmed:meshHeadingpubmed-meshheading:7888301-...lld:pubmed
pubmed-article:7888301pubmed:meshHeadingpubmed-meshheading:7888301-...lld:pubmed
pubmed-article:7888301pubmed:meshHeadingpubmed-meshheading:7888301-...lld:pubmed
pubmed-article:7888301pubmed:meshHeadingpubmed-meshheading:7888301-...lld:pubmed
pubmed-article:7888301pubmed:year1994lld:pubmed
pubmed-article:7888301pubmed:articleTitleAnalogues of the thrombin receptor tethered-ligand enhance mesangial cell proliferation.lld:pubmed
pubmed-article:7888301pubmed:affiliationDepartment of Renal Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, PA 19406-0939.lld:pubmed
pubmed-article:7888301pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7888301lld:pubmed